The perplexing role of immuno-oncology drugs in osteosarcoma

Alannah Smrke,Yuen B Tam,Peter M Anderson,Robin L Jones,Paul H Huang

Journal of Bone Oncology（2021）

引用 3|浏览13

暂无评分

摘要

•Osteosarcoma outcomes have not improved since use of cytotoxic chemotherapy.•Addition of macrophage activators and interferon have been disappointing.•Combination therapies may be needed to exploit the role of the immune system.

查看译文

关键词

Osteosarcoma,Systemic therapy,Immunotherapy,PDL1

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要